Market Place
Sourcing Support
Epic Bio`s EPI-321 IND Data At FSHD Research Congress
07 Jun 2024 //
GLOBENEWSWIRE
Epic Bio to Participate in Fireside Chat at Stifel`s Genetic Medicines Forum
23 May 2024 //
GLOBENEWSWIRE
Epic Bio`s EPI-321, Epigenetic Editing At ASGCT
23 Apr 2024 //
GLOBENEWSWIRE
Epic Bio to Participate in Fireside Chat at Genetic Medicine Forum
10 Apr 2024 //
GLOBENEWSWIRE
Epic Bio Presents at ASGCT 27th Annual Meeting
09 Apr 2024 //
GLOBENEWSWIRE
Epic Bio to Participate in a Fireside Chat at the Cantor Virtual MD Symposium
01 Apr 2024 //
GLOBENEWSWIRE
Epic Bio to Present at the Upcoming Charles River Cell and Gene Therapy Summit
13 Mar 2024 //
GLOBENEWSWIRE
Epic Bio to Present at the Upcoming CRISPR2.0 Conference
21 Nov 2023 //
GLOBENEWSWIRE
FDA Grants Orphan Drug Designation to EPI-321
16 Nov 2023 //
GLOBENEWSWIRE
Epic Bio to Participate in Upcoming Investor Conference
07 Nov 2023 //
GLOBENEWSWIRE
Kite and Epic Bio Announce Collaboration to Develop New Therapies for Cancer
31 Oct 2023 //
BUSINESSWIRE
Kite enlists Epic to apply epigenetic editing in creating next-gen CAR-T cells
31 Oct 2023 //
ENDPTS
Epic Bio Reports New Data on Hypercompact Cas Proteins Optimized
26 Oct 2023 //
GLOBENEWSWIRE
Epic to Present at the Upcoming Annual European Society of Gene and Cell Therapy
19 Oct 2023 //
GLOBENEWSWIRE
Epic Announces the Appointment of Weston Miller, M.D., as Chief Medical Officer
17 Oct 2023 //
GLOBENEWSWIRE
Epic Bio to Present at the Upcoming BMO Life Sciences Private Company Showcase
05 Oct 2023 //
GLOBENEWSWIRE
Epic Bio to Present Preclinical Data at 28th International Annual Congress
28 Sep 2023 //
GLOBENEWSWIRE
Epic Bio to Present at Upcoming BMO Biopharma Spotlight Series Event
19 Sep 2023 //
GLOBENEWSWIRE
Epic Bio Reports Discovery of Exceptionally Durable Gene Activators
14 Sep 2023 //
GLOBENEWSWIRE
Epic Bio Presents Compelling Data Supporting Clinical of EPI-321 for FSHD
16 Jun 2023 //
GLOBENEWSWIRE
Epic Bio to Participate in a Fireside Chat at Stifel Genetic Medicines Day 2023
23 May 2023 //
GLOBENEWSWIRE
Epic Presents Data on EPI-321 for Facioscapulohumeral Muscular Dystrophy
19 May 2023 //
GLOBENEWSWIRE
Epic Bio to Present Preclinical Data at ASGCT (ASGCT) 26th Annual Meeting
04 May 2023 //
GLOBENEWSWIRE
SOLVE FSHD Invests in Epic Bio to Advance Potentially Curative Therapy
18 Apr 2023 //
GLOBENEWSWIRE
Epic Bio to Participate in the BMO Virtual Spotlight Series
15 Nov 2022 //
BUSINESSWIRE
Epic Bio Presents First Data Supporting Persistent
31 Oct 2022 //
BUSINESSWIRE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.